BLOG

Stuff that matters.

Trump tells pharma CEOs to cut costs and bring back jobs

07 Feb 2017

President Donald Trump met with CEOs of some of America's biggest and most profitable pharmaceutical companies at the White House on Tuesday, saying he expects them to lower drug prices and bring jobs back to the United States. 'You folks have done a terrific job over the years, but we...

Read More

Abbott to make India hub of global research and development for branded generics.

07 Feb 2017

At a time when multinational drug companies are scaling down their research and development investments in India, citing lax patent rules and increasing regulatory interventions, the US based multinational Abbott is planning to make India its global hub for innovation and development (I&D), in branded...

Read More

Cipla To Sell Animal Health Business In South Africa.

06 Mar 2017

Under the agreements, Cipla will divest its 100 per cent stake in Cipla Agrimed Proprietary South Africa and Cipla Vet Proprietary, South Africa, it said. New Delhi: Pharma firm Cipla today said it plans to sell its animal health business in South Africa and Sub-Saharan Africa for a consideration...

Read More

US Pharma Sector Demands Keeping India In Patent Violator List

06 Mar 2017

  Among the key issues of concern for the US pharma sector in India are unpredictable IP environment, high tariffs and taxes on medicines among others. Press Trust of India  Washington: America's pharma sector has asked US Trade Representative (USTR) to continue to keep India...

Read More

Indian-American Entrepreneur Under Consideration To Lead USFDA.

06 Mar 2017

  Balaji Srinivasan met Trump at the Trump Towers in New York on Thursday. No official announcement has been made yet. Press Trust of India       Washington: Indian-American Balaji S Srinivasan, a successful Silicon Valley-based entrepreneur and CEO of a...

Read More

Pharma makes most super rich in India

08 Mar 2017

Over 15 per cent of Indian billionaires are from pharma, followed by manufacturing.   Mumbai: The pharmaceutical sector has produced the most number of ultra high net-worth individuals in India, accounting for almost 16 per cent of the total 132 wealthy Indians featured in the latest...

Read More

Government gets Rs 672 crore fine from pharma companies for overcharging.

15 Mar 2017

NEW DELHI: Drug pricing regulator NPPA has received Rs 672.28 crore fine till date from pharmaceutical companies for overcharging, Parliament was informed today.  Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging...

Read More

Get in touch

For any questions or suggestions, please feel free to get in touch with us

Get in touch

Social